Related Experiment Videos
Plaque modification with tetracycline: enhanced tissue ablation with the excimer laser
T P Smith1, A H Cragg, S K Landas
1Department of Radiology, University of Iowa School of Medicine, Iowa City 52242.
Radiology
|March 1, 1990
Summary
Tetracycline, a photosensitizing agent, significantly enhances atherosclerotic plaque ablation by the xenon-fluorine excimer laser. This finding suggests improved laser treatments for atherosclerosis by utilizing tetracycline.
Area of Science:
- Cardiovascular Research
- Biomedical Optics
- Pharmacology
Background:
- Tetracycline selectively accumulates in atherosclerotic plaque.
- Tetracycline is a known photosensitizing agent.
- Excimer lasers are used in medical treatments.
Purpose of the Study:
- To investigate if tetracycline enhances the photoablative effects of the ultraviolet xenon-fluorine excimer laser on atherosclerotic plaque.
- To analyze the impact of tetracycline on laser ablation depth, width, and thermal injury.
Main Methods:
- Four cadaveric aortic samples were exposed to tetracycline, and four to saline.
- Ninety-three sites were subjected to excimer laser energy.
- Histological analysis assessed crater depth, width, and thermal injury.
Main Results:
- Crater depth was not significantly different in normal versus atherosclerotic sites without tetracycline.
- Atherosclerotic sites treated with tetracycline showed significantly deeper craters than normal, exposed sites.
- Tetracycline exposure and plaque characteristics had independent and additive effects on crater width and thermal injury.
Conclusions:
- Tetracycline significantly enhances atherosclerotic plaque ablation when using the xenon-fluorine excimer laser.
- This synergistic effect may offer improved therapeutic strategies for treating atherosclerosis with laser technology.